Table 1. Baseline characteristics of patients with and without sarcopenia.
| Characteristics | Sarcopenia (n=38) | Non-sarcopenia (n=32) | P |
|---|---|---|---|
| Recipient factors | |||
| Age, years | 43 (±9.7) | 40 (±7.7) | 0.157 |
| BMI, kg/m2 | 21.6 (±2.2) | 24.5 (±2.8) | <0.001 |
| Creatinine, mmol/L | 74.6 (±21.8) | 74.1 (±13.9) | 0.908 |
| Albumin, mmol/L | 33.5 (±6.9) | 37.2 (±6.8) | 0.029 |
| TBL, mmol/L | 88.9 (±11.9) | 27.6 (±18.9) | 0.005 |
| INR | 1.48 (±0.47) | 1.27 (±0.27) | 0.033 |
| HBsAg, n (%) | 30 (78.9) | 30 (93.8) | 0.097 |
| AFP >400 ng/mL, n (%) | 9 (23.7) | 9 (28.1) | 0.786 |
| MELD score | 16.6 (±6.9) | 12.7 (±3.8) | 0.004 |
| Progressive hyperbilirubinemia, n (%) | 10 (26.3) | 2 (6.3) | 0.031 |
| Refractory ascites, n (%) | 9 (23.7) | 2 (6.3) | 0.055 |
| History of varicose veins bleeding, n (%) | 2 (5.3) | 1 (3.1) | 1.000 |
| Spontaneous bacterial peritonitis, n (%) | 2 (5.3) | 0 (0) | 0.496 |
| Hepatic encephalopathy, n (%) | 3 (7.9) | 0 (0) | 0.245 |
| Pretransplant infection, n (%) | 4 (10.5) | 1 (3.1) | 0.366 |
| Pretransplant hospital stay, n (%) | 17 (44.7) | 13 (40.6) | 0.811 |
| Donor and surgical factors | |||
| Donor age, years | 38.4 (±10.2) | 37.7 (±9.3) | 0.747 |
| Donor male, n (%) | 23 (60.5) | 22 (68.8) | 0.617 |
| ABO incompatible, n (%) | 6 (15.8) | 10 (31.3) | 0.158 |
| Donor BMI, kg/m2 | 22.6 (±2.6) | 23.7 (±2.5) | 0.082 |
| GRWR | 0.96 (±0.23) | 0.88 (±0.15) | 0.097 |
| Duration of operation, hour | 10.6 (±2.6) | 10.2 (±2.2) | 0.460 |
| Cold ischemia time, hour | 2.1 (±2.2) | 2.2 (±2.7) | 0.818 |
BMI, body mass index; TBL, total bilirubin; INR, international normalized ratio; HBsAg, hepatitis B surface antigen; AFP, alpha fetoprotein; MELD, model for end-stage liver disease score; GRWR, graft-to-recipient weight ratio.